Last updated on December 2019

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN (NCT03518086).

Clinical Study Identifier: NCT03524092

Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )
If you would like to be informed of other studies that may be of interest to you, you may sign up for CenterWatch.com's Patient Notification Service.